Arginase Inhibition in Ischemia-reperfusion Injury

Clinical trial NCT02009527 · COMPLETED

Trial details

NCT number: NCT02009527
Sponsor: Karolinska Institutet
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Coronary Artery Disease Type 2 Diabetes Mellitus

Start date: 2012-01-01
Primary completion: 2013-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.